© 1994 British Society for Rheumatology
case-report |
ACUTE RENAL FAILURE OCCURRING IN SCLERODERMA TREATED WITH CYCLOSPORIN A: A REPORT OF THREE CASES


*Departments of Rheumatology Royal Free Hospital Hampstead, London NW3 2QG
Nephrology and Transplantation, Royal Free Hospital Hampstead, London NW3 2QG
Cyclosporin A, which is a nephrotoxic agent, has been a mainstay antirejection drug in heart, kidney and lung transplant programmes for about 10 yr. Renal transplant physicians have become adept in balancing its powerful immunosuppressive effects with its undoubted potential nephrotoxicity. Here we report three of eight systemic sclerosis (SSc) patients treated with cyclosporin A who developed acute renal failure. Consideration is given to the evidence of benefit from this agent in SSc and to the management of acute hypertensive renal failure in this disease.
KEY WORDS: Systemic sclerosis, Connective tissue disease, Nephrotoxicity
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
C. P. Denton Renal manifestations of systemic sclerosis--clinical features and outcome assessment Rheumatology, October 1, 2008; 47(suppl_5): v54 - v56. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Penn, A.J. Howie, E.J. Kingdon, C.C. Bunn, R.J. Stratton, C.M. Black, A. Burns, and C.P. Denton Scleroderma renal crisis: patient characteristics and long-term outcomes QJM, August 1, 2007; 100(8): 485 - 494. [Abstract] [Full Text] [PDF] |
||||

